Table 1. Group characteristics.
| Characteristics | Individuals with CAD (n = 13) | Individuals without atherosclerosis (n = 13) |
|---|---|---|
| Age (years) | 59.8 ± 9.7 | 52.2 ± 10.4 |
| Sex (% men, n) | 100 (13) | 100 (13) |
| BMI (kg/m2) | 27.8 ± 2.8 | 25.8 ± 2.5 |
| SBP (mm Hg) | 133 ± 15 | 126 ± 10 |
| DBP (mm Hg) | 90 ± 8* | 84 ± 6 |
| Hypertension (%, n) | 93 (12)** | 31 (4) |
| Current smoking (%, n) | 23 (3) | 31 (4) |
| Calcium score (HU) | 445 [213-781]** | 0 [0] |
| Total Plaque score (0–16)‡ | 14 [9-15]*** | 0 [0] |
| Lipid-lowering therapy (%, n) | 77 (10)*** | 8 (1) |
| Acetylsalicylic acid use (%, n) | 69 (9)*** | 0 (0) |
| ACE-inhibitor use (%, n) | 23 (3) | 8 (1) |
| β-blocker use (%, n) | 23 (3) | 8 (1) |
| Glucose (mmol/L) | 5.9 ± 0.8 | †5.7 ± 0.7 |
| Creatinine (µmol/L) | 89 ± 14 | 91 ± 16 |
| Tchol (mmol/L) | 4.51 ± 0.86** | 5.61 ± 0.61 |
| LDLc (mmol/L) | †2.52 ± 0.97** | 3.56 ± 0.64 |
| HDLc (mmol/L) | 1.25 ± 0.31 | 1.51 ± 0.34 |
| TG (mmol/L) | 1.98 ± 1.97 | 1.20 ± 0.38 |
| nHDLc (mmol/L) | 3.26 ± 1.06* | 4.11 ± 0.75 |
Data are reported as mean ± SD, as mean (number of participants), or as median [interquartile range] and compared with the appropriate statistical tests. ‡ TPS was calculated for participants with a calcium score of <400 HU (n = 6). † Data is missing for one participant. * indicates p<0.05, **: p<0.01, ***: p<0.001.